You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Human PSMA MAb Radioimmunotherapy for Prostate Cancer

    SBC: PROGENICS PHARMACEUTICALS, INC.            Topic: N/A

    Prostate cancer is the most common cancer of men in the United States with approximately 189,000 new cases and 30,000 deaths in 2002. Recurrent disease can be controlled temporarily with androgen ablation. However, almost all prostate carcinomas eventuall

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  2. Development of PSMA-based recombinant protein vaccines

    SBC: PROGENICS PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Prostate cancer is the most common cancer of men in the United States with approximately 189,000 new cases and 30,000 deaths in 2002. Recurrent disease can be controlled temporarily with androgen ablation. However, alm

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  3. Hepatic Growth Factor Mimetic for Liver Fibrosis

    SBC: Angion Biomedica Corp.            Topic: N/A

    DESCRIPTION (provided by applicant): Hepatic fibrosis, a disease affecting tens of millions of patients worldwide, is the liver scarring response to chronic injury from viral hepatitis B or C, excessive alcohol use, iron overload or extrahepatic obstr

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  4. ER beta selective agonist coronary protection-menopause

    SBC: DIMERA, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This Phase II project continues with studies of rhesus monkeys in vivo to further test, and develop toward approval as a drug for human use, a novel estrogen receptor beta (ERbeta or ERb) selective (over ERalpha or ERa

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  5. Generation of a zebrafish insertional mutation library

    SBC: ZNOMICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): At the present time it is not possible to rapidly and inexpensively obtain a vertebrate knockout in a gene of choice, or to readily perform whole genome forward genetic screening in a vertebrate. The goal of this P

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. Refanalin for Liver Transplantation

    SBC: Angion Biomedica Corp.            Topic: N/A

    DESCRIPTION (provided by applicant): Orthotopic liver transplantation is the most effective treatment for patients with end-stage liver disease. Ischemia-reperfusion injury associated with the retrieval, storage and transplantation of livers is a major

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  7. Human Monoclonal Antibodies for Bioterrorism Defense

    SBC: VACCINEX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Variola virus, the etiologic agent of smallpox, and the closely related vaccinia virus, which is the basis for the smallpox vaccine, have evolved a complex strategy to evade host defenses in the individual and to permi

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  8. A Novel Assay for Measurement of PCB Aroclors

    SBC: SYNTHERICA CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Polychlorinated biphenyls (PCBs) are a major public health hazard. We intend to develop the novel Synthetide(tm)-based test array described in Phase I for the measurement of polychlorinated biphenyls (PCBs) in the

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  9. Comprehensive Positioning Management System

    SBC: VESTICON            Topic: N/A

    DESCRIPTION (provided by applicant): Vesticon, Inc. is developing a comprehensive evaluation and management system for positional manifestations of vestibular disorders (Comprehensive Positional Management System) (CPM System) for application at m

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Detecting Crack and Other Cocaine Use With FastPatches

    SBC: SOCIAL SCIENCES INNOVATIONS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): PharmChem Inc. has developed a new sweat patch product, the FastPatch TM, which reduces minimum wear times to detect cocaine and most other drugs of abuse from the full day typically required with standard sweat patche

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government